Literature DB >> 12657743

Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems.

Franziska Boess1, Markus Kamber, Simona Romer, Rodolfo Gasser, Dieter Muller, Silvio Albertini, Laura Suter.   

Abstract

Microarray technology allows the simultaneous analysis of mRNA expression levels of thousands of genes. In the field of toxicogenomics, this technology could help to identify potentially unsafe compounds based on the changes in mRNA expression patterns they induce. Rodent in vivo and in vitro systems are currently the experimental models of choice for predictive toxicology, especially in early phases of development. This study characterizes several hepatic in vitro systems based on mRNA expression profiles, comparing them to gene expression in liver tissue. The in vitro systems investigated comprise two rat liver cell lines (BRL3A and NRL clone 9), primary hepatocytes in conventional monolayer or in sandwich culture, and liver slices. The results demonstrate that liver slices exhibit the strongest similarity to liver tissue regarding mRNA expression, whereas the two cell lines are quite different from the whole liver. We were able to identify genes with strong changes in expression levels in all or at least one of the in vitro systems relative to whole liver. In particular, for some cytochrome P450s the differences observed on the mRNA expression level were paralleled by protein expression and enzymatic activity. In addition, the effect of time in culture was assessed. We were able to show a profound effect of the duration of culture. Expression patterns change most rapidly soon after cell isolation and culture initiation and stabilize with time in culture. The findings are discussed with respect to the usefulness of the various hepatic in vitro systems for microarray-based toxicological testing of compounds.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12657743     DOI: 10.1093/toxsci/kfg064

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  66 in total

1.  Endothelial arginase II responds to pharmacological inhibition by elevation in protein level.

Authors:  Karina Krotova; Jawaharlal M Patel; Edward R Block; Sergey Zharikov
Journal:  Mol Cell Biochem       Date:  2010-06-19       Impact factor: 3.396

2.  Cold storage of porcine hepatocyte spheroids for spheroid bioartificial liver.

Authors:  Yi Li; Harvey S Chen; Mohammed Shaheen; Dong Jin Joo; Bruce P Amiot; Piero Rinaldo; Scott L Nyberg
Journal:  Xenotransplantation       Date:  2019-04-10       Impact factor: 3.907

3.  A novel 3D liver organoid system for elucidation of hepatic glucose metabolism.

Authors:  Yanhua Lu; Guoliang Zhang; Chong Shen; Korkut Uygun; Martin L Yarmush; Qin Meng
Journal:  Biotechnol Bioeng       Date:  2011-10-19       Impact factor: 4.530

Review 4.  Toxicogenomics in drug discovery and drug development: potential applications and future challenges.

Authors:  Tin Oo Khor; Sherif Ibrahim; Ah-Ng Tony Kong
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

5.  Regulation of surfactant protein and defensin mRNA expression in cultured ovine type II pneumocytes by all-trans retinoic acid and VEGF.

Authors:  B Grubor; D K Meyerholz; T Lazic; M M DeMacedo; R J Derscheid; J M Hostetter; J M Gallup; J C DeMartini; M R Ackermann
Journal:  Int J Exp Pathol       Date:  2006-10       Impact factor: 1.925

6.  Gene expression profiling and its practice in drug development.

Authors:  Murty V Chengalvala; Vargheese M Chennathukuzhi; Daniel S Johnston; Panayiotis E Stevis; Gregory S Kopf
Journal:  Curr Genomics       Date:  2007-06       Impact factor: 2.236

7.  Precision-cut human liver slice cultures as an immunological platform.

Authors:  Xia Wu; Jessica B Roberto; Allison Knupp; Heidi L Kenerson; Camtu D Truong; Sebastian Y Yuen; Katherine J Brempelis; Marianne Tuefferd; Antony Chen; Helen Horton; Raymond S Yeung; Ian N Crispe
Journal:  J Immunol Methods       Date:  2018-02-01       Impact factor: 2.303

Review 8.  Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity.

Authors:  Brandon Swift; Nathan D Pfeifer; Kim L R Brouwer
Journal:  Drug Metab Rev       Date:  2010-08       Impact factor: 4.518

9.  Pathophysiological relevance of proteomics investigations of drug-induced hepatotoxicity in HepG2 cells.

Authors:  Hartmut Jaeschke; Mitchell R McGill; Anup Ramachandran
Journal:  Toxicol Sci       Date:  2011-03-07       Impact factor: 4.849

10.  In vitro models for liver toxicity testing.

Authors:  Valerie Y Soldatow; Edward L Lecluyse; Linda G Griffith; Ivan Rusyn
Journal:  Toxicol Res (Camb)       Date:  2012-11-23       Impact factor: 3.524

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.